series-b
Stage
1
Investors
About
Vanqua Bio is a biopharmaceutical company developing novel therapies targeting neurodegenerative diseases such as Parkinson’s disease, Dementia with Lewy Bodies, and Alzheimer’s disease by focusing on critical neuronal pathways and innate immune system modulation.
Explore Vanqua Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.